GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $21.93 $29.93 Thursday, 18th Apr 2024 ARWR stock ended at $22.61. This is 0.355% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.97% from a day low at $21.93 to a day high of $22.80.
90 days $21.93 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2021-02-10 $90.00 $92.60 $87.01 $87.48 940 760
2021-02-09 $88.41 $91.10 $87.66 $89.80 549 820
2021-02-08 $89.64 $90.47 $86.12 $88.41 1 156 316
2021-02-05 $82.50 $91.70 $78.55 $90.47 1 459 657
2021-02-04 $81.61 $84.89 $79.77 $83.92 915 654
2021-02-03 $79.92 $81.89 $79.45 $80.33 568 201
2021-02-02 $80.78 $82.00 $79.95 $80.52 713 377
2021-02-01 $78.03 $80.40 $77.28 $79.76 543 462
2021-01-29 $78.39 $80.89 $76.31 $77.17 978 039
2021-01-28 $78.16 $79.29 $76.50 $77.75 711 781
2021-01-27 $79.55 $81.93 $75.03 $76.82 1 001 078
2021-01-26 $84.29 $85.88 $80.86 $81.14 655 390
2021-01-25 $81.85 $84.67 $80.29 $84.13 696 485
2021-01-22 $79.81 $82.24 $79.50 $82.07 820 276
2021-01-21 $83.58 $84.12 $79.49 $80.02 558 845
2021-01-20 $82.59 $84.98 $82.40 $83.44 656 129
2021-01-19 $80.61 $83.45 $80.61 $82.15 538 566
2021-01-15 $81.90 $84.35 $80.52 $80.74 650 556
2021-01-14 $80.95 $84.12 $80.40 $82.86 480 067
2021-01-13 $82.11 $84.55 $80.89 $81.00 709 162
2021-01-12 $80.42 $82.93 $80.01 $82.69 550 420
2021-01-11 $79.00 $81.22 $78.03 $80.11 829 304
2021-01-08 $78.85 $82.25 $78.10 $79.88 937 060
2021-01-07 $75.00 $79.49 $75.00 $79.47 971 115
2021-01-06 $71.62 $74.74 $70.11 $74.38 1 709 559
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT